HomeMarketsSharesThermo Fisher Scientific

Trade Thermo Fisher Scientific - TMO CFD

Market is not available at the momentMarket information is presented
as of 2026-05-22 19:45:42
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.3
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021179 %
(-$4.24)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02118%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.001043 %
(-$0.21)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00104%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close448.81
Open449.13
1-Year Change12.91%
Day's Range444.44 - 451.96

Trade Thermo Fisher Scientific - TMO CFD

Thermo Fisher Scientific Inc. (TMO) is a supplier of scientific laboratory products, instruments, software and other tools. The company was formed in a tax-free stock-for-stock merger of Thermo Electron Corporation with Fisher Scientific International Inc. in 2006. 

The company provides services through various brands including Thermo Fishers, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. 

Thermo Fisher works on accelerating life sciences research by solving complex analytical challenges. Its products aim to increase productivity in laboratories and improve patient health through diagnostics and therapy development. 

The four segments that Thermo Fisher Scientific caters to are industrial and applied research, diagnostics and healthcare, academic and government research, and pharmaceuticals and biotechnology. 

As of June 2022, Thermo Fisher has developed Orbitrap Exploris MX mass spectrometer, cell therapy workflow solutions, Oncomine Dx Target Test and several other solutions that aim to make the diagnosis of infections and diseases easier and enable production of drugs and vaccines. 

Thermo Fisher Scientific Inc. stock is trading on the New York Stock Exchange (NYSE) under the ticker symbol TMO. You can follow live TMO stock movement and price history, and stay on top of the latest TMO share value at Capital.com.

Latest shares articles

Nexi S.p.A. Stock Forecast | Q1 2026 Earnings and Guidance
Nexi S.p.A. stock forecast: Q1 2026 earnings and guidance
Nexi is an Italian payments group listed in Milan. Its latest results reaffirmed 2026 guidance, while Reuters has reported preliminary CVC takeover interest. Explore third-party NEXI price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:15, 21 May 2026
Leonardo Stock Forecast | Q1 2026 Earnings and Guidance
Leonardo stock forecast: Q1 2026 earnings and guidance
Leonardo is an Italian defence and aerospace group whose Q1 2026 results showed higher orders, revenue growth and confirmed full-year guidance. Explore third-party LDO price targets and technical analysis. Past performance is not a reliable indicator of future results.
13:30, 19 May 2026
NVIDIA logo displayed on a smartphone screen with a glowing green NVIDIA background
Nvidia stock forecast: H200 China chip clearance
NVIDIA is a US semiconductor company whose H200 chip sales to selected Chinese firms and Q1 FY27 earnings on 20 May 2026 are in focus. Explore third-party NVDA price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:01, 19 May 2026
Intesa Sanpaolo Stock Forecast | Record Q1 Net Income
Intesa Sanpaolo stock forecast: Record Q1 net income
Intesa Sanpaolo is an Italian banking group listed on Borsa Italiana. In Q1 2026, it reported net income of €2.8bn and return on equity of 21%. Explore third-party ISP price targets and technical analysis. Past performance is not a reliable indicator of future results.
16:07, 14 May 2026
Related News
Public TechnologiesEurope
12:32 (UTC), 20 May 2026
Thermo Fisher hosts 2026 Investor Day, targets 7% organic revenue CAGR
GlobeNewswireEurope
12:30 (UTC), 20 May 2026
Banzai International, Inc. Announces $7.8 Million Debt Elimination
Public TechnologiesEurope
14:23 (UTC), 19 May 2026
Acuvi appoints Jens Lagergren CFO, effective June 1
Public TechnologiesEurope
12:03 (UTC), 18 May 2026
Kyverna names Greg Martini CFO, succeeding Marc Grasso
GlobeNewswireEurope
20:10 (UTC), 15 May 2026
Banzai Reports First Quarter 2026 Financial Results
Public TechnologiesEurope
21:22 (UTC), 13 May 2026
Kairos Pharma Q1 net loss widens to $1.65 million; no revenue
Public TechnologiesEurope
20:10 (UTC), 13 May 2026
Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI
Reuters NewsEurope
12:08 (UTC), 13 May 2026
Spruce Biosciences Q1 net loss narrows on lower expenses

User feedback and ratings

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-19
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
G****

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

2025-06-29
p*******

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start trading